NetworkNewsBreaks – Predictive Oncology Inc. (NA
Post# of 280
Predictive Oncology (NASDAQ: POAI), an artificial intelligence (“AI”) and data-driven functional precision medicine company with the mission of improving the standard of care for cancer patients through innovative data-driven products and services, this morning announced the broadcast of a NetworkNewsAudio (“NNA”) interview with Stuart Smith of NetworkNewsWire (“NNW”). Predictive Oncology CEO Dr. Carl Schwartz joined Smith to discuss several corporate and scientific milestones that have been achieved by the company in 2019, as well as POAI’s strategy moving forward. “Predictive Oncology and its subsidiaries, in collaboration with key players in the pharmaceutical, diagnostic and biotech industries, are finding success in several arenas,” Predictive Oncology CEO Dr. Carl Schwartz stated in the interview.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer